Novel mechanism of salt-induced glomerular injury: critical role of eNOS and angiotensin II

J Hypertens. 2011 Aug;29(8):1528-35. doi: 10.1097/HJH.0b013e328348ca95.

Abstract

Objectives: The present study was undertaken to examine the role of endothelial nitric oxide synthase (eNOS) in salt-sensitive renal injury.

Methods: The effects of high-salt diet on renal injury were compared between wild-type and eNOS-/- mice. To examine the role of glomerular angiotensin II and oxidative stress, high-salt fed eNOS-/- mice were given irbesartan, an angiotensin receptor blocker, or tempol, an antioxidant.

Results: Four weeks of high-salt diet in wild-type mice, which rapidly caused glomerular eNOS activation and subsequent increase in nitric oxide, did not at all induce renal injury, indicating that wild-type mice are salt-resistant. On the contrary, high-salt diet in eNOS-/- mice, which little increased nitric oxide, rapidly increased urinary albumin excretion, followed by glomerular macrophage infiltration and glomerular sclerosis. Thus, eNOS deficiency caused salt-sensitive glomerular injury. Salt-induced glomerular injury in eNOS-/- mice was preceded by rapid enhancement of glomerular superoxide followed by enhancement of glomerular endothelial angiotensinogen and angiotensin II. Irbesartan and tempol, independently of blood pressure, markedly prevented salt-induced glomerular injury in eNOS-/- mice, and these protective effects were attributed to the attenuation of glomerular oxidative stress and glomerular angiotensinogen-derived angiotensin II.

Conclusion: We propose that eNOS dysfunction plays a causative role in salt-induced glomerular injury, through augmentation of glomerular oxidative stress-induced angiotensinogen.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Albuminuria / physiopathology
  • Angiotensin II / physiology*
  • Angiotensin II Type 1 Receptor Blockers / pharmacology
  • Angiotensin II Type 1 Receptor Blockers / therapeutic use
  • Animals
  • Antioxidants / pharmacology
  • Antioxidants / therapeutic use
  • Biphenyl Compounds / pharmacology
  • Biphenyl Compounds / therapeutic use
  • Blood Pressure / drug effects
  • Cyclic N-Oxides / pharmacology
  • Cyclic N-Oxides / therapeutic use
  • Disease Models, Animal
  • Glomerulonephritis / chemically induced*
  • Glomerulonephritis / physiopathology*
  • Glomerulonephritis / prevention & control
  • Irbesartan
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Nitric Oxide Synthase / metabolism
  • Nitric Oxide Synthase Type III / deficiency
  • Nitric Oxide Synthase Type III / genetics
  • Nitric Oxide Synthase Type III / physiology*
  • Oxidative Stress / drug effects
  • Oxidative Stress / physiology*
  • Sodium Chloride, Dietary / adverse effects*
  • Sodium Chloride, Dietary / pharmacology
  • Spin Labels
  • Tetrazoles / pharmacology
  • Tetrazoles / therapeutic use

Substances

  • Angiotensin II Type 1 Receptor Blockers
  • Antioxidants
  • Biphenyl Compounds
  • Cyclic N-Oxides
  • Sodium Chloride, Dietary
  • Spin Labels
  • Tetrazoles
  • Angiotensin II
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type III
  • Irbesartan
  • tempol